Education
About Us
Working with TipRanks
Follow Us
Psyence Group (TSE:PSYG)
:PSYG
PSYG Stock Chart & Stats
Day’s Range― - ―
52-Week RangeC$0.01 - C$0.04
Previous CloseN/A
Volume20.00K
Average Volume (3M)17.01K
Market Cap
C$2.11M
Enterprise ValueC$22.97M
Total Cash (Recent Filing)C$1.11M
Total Debt (Recent Filing)C$12.41M
Price to Earnings (P/E)―
Beta0.47
Next Earnings
Jul 08, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.50
Shares Outstanding140,451,420
10 Day Avg. Volume5,281
30 Day Avg. Volume17,012
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.50
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Psyence Group News
PremiumCompany Announcements
Psyence Group Announces Share Consolidation for Strategic Growth
PremiumCompany Announcements
Psyence Biomedical Enhances Scientific Advisory Board with New Appointment
PremiumCompany Announcements
Psyence Biomedical Strengthens Research with New Advisory Board ChairPremiumCompany Announcements
Psyence Group Sells Stake to Psyence Biomedical
PremiumCompany Announcements
Psyence Group Expands Psilocybin Clinical Trials
PremiumCompany Announcements
Psyence Group Enhances Liquidity with Equity Swap
PremiumCompany Announcements
Psyence Group Sells Stake in PsyLabs to AssociatePremiumCompany Announcements
Psyence Biomed Advances Psilocybin Mental Health Treatments---
Options Prices
Currently, No data available
---
Ownership Overview
3.88% Insiders
―
Mutual Funds
― Other Institutional Investors
96.12% Public Companies and
Individual Investors
PSYG FAQ
What was Psyence Group’s price range in the past 12 months?
Psyence Group lowest stock price was C$0.01 and its highest was C$0.04 in the past 12 months.
What is Psyence Group’s market cap?
Psyence Group’s market cap is C$2.11M.
When is Psyence Group’s upcoming earnings report date?
Psyence Group’s upcoming earnings report date is Jul 08, 2025 which is in 81 days.
How were Psyence Group’s earnings last quarter?
Psyence Group released its earnings results on Feb 28, 2025. The company reported -C$0.004 earnings per share for the quarter, missing the consensus estimate of N/A by -C$0.004.
Is Psyence Group overvalued?
According to Wall Street analysts Psyence Group’s price is currently Overvalued.
Does Psyence Group pay dividends?
Psyence Group does not currently pay dividends.
What is Psyence Group’s EPS estimate?
Psyence Group’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Psyence Group have?
Psyence Group has 140,451,420 shares outstanding.
What happened to Psyence Group’s price movement after its last earnings report?
Psyence Group reported an EPS of -C$0.004 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Psyence Group?
Currently, no hedge funds are holding shares in TSE:PSYG
---
Company Description
Psyence Group
Psyence Group Inc., a life science biotechnology company, engages in the commercial psilocybin mushroom cultivation and production activities. Its natural psilocybin is used for the treatment of a range of mental health disorders and other medical conditions. The company is developing pharmaceutical preparations of psilocybin doses to help heal psychological trauma and diagnosable disorders, including anxiety, depression, post-traumatic stress disorder, and grief and bereavement. It also focuses on the development, distribution, and sale of over-the-counter non psilocybin containing functional mushroom nutraceutical products under the GOODMIND brand. Psyence Group Inc. was founded in 2019 and is based in Toronto, Canada.
---
Technical Analysis
---